Mounjaro®

Mounjaro (tirzepatide) belongs to the dual GIP and GLP-1 receptor agonist class, offering a unique approach to blood sugar control and weight management. By activating these receptors, tirzepatide helps regulate glucose levels, reduces appetite, and extends the feeling of fullness after meals.

Get Started

Lowers A1C levels
Helps you feel full faster, longer
Improves the way your body responds to sugars
Mounjaro® is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate*

One subcutaneous injection weekly as directed by your healthcare provider

Common side effects with Mounjaro include:

Redness & itching at the injection site
Loss of appetite
Tiredness
Nausea
Upset stomach
Diarrhea, or constipation may occur

* Only available if prescribed after an online consultation with a healthcare provider.
* This page has been medically reviewed
* Actual price to customer will depend on product and subscription plan purchase.

Member Success Stories

Weight Loss

Ana

Lost 37lbs

“Since I started using Zepbound, I've felt a positive shift in my overall well-being. It's not just a product; it's become an essential part of my lifestyle, helping me feel my best every day..”

Suzie

Lost 34lbs

“Mounjaro totally changed the game for me! I lost the extra weight without even trying, and now I've got this crazy energy boost. It's like my secret weapon for a healthier, happier me!”

Letitia

Lost 39lbs

“This little wonder has not only helped me manage my blood sugar levels effectively but has also given me a renewed sense of control and vitality. Grateful for the positive impact it's had on my life”

What are GLP-1s?

GLP-1s are ground breaking weight loss medications that work differently from older generations like phentermine.

They focus on important metabolic pathways to achieve sustainable weight loss. Our providers prescribe various GLP-1 medications, including tirzepatide, semaglutide and liraglutide, which you might recognize as Wegovy®, Saxenda®, Ozempic®, or Mounjaro®.

A better option for weight loss

People taking once-weekly Mounjaro® lost more weight than those taking Ozempic® 1mg*

*Mounjaro is not a weight loss drug. Individual results may vary. In this study conducted by Eli Lily, the Mounjaro 5-mg, 10-mg, and 15-mg doses were compared to Ozempic 1 mg. The average starting weight was between 204 to 209 pounds.